A retrospective study in clinical course of Heicobacter pylori eradication therapy
Not Applicable
- Conditions
- H.pylori infected patients
- Registration Number
- JPRN-UMIN000032351
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Vonoprazan-based triple therapy was effective as susceptibility-guided triple therapy for H. pylori eradication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 427
Inclusion Criteria
Not provided
Exclusion Criteria
patient who refused the therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is non-inferiority of vonoprazan-based therapy for other regimens including PPI-based therapy.
- Secondary Outcome Measures
Name Time Method